Thomas Eldridge Stinchcombe, MD

Professor of Medicine
Member of the Duke Cancer Institute
Email address thomas.stinchcombe@duke.edu

Education and Training

  • Hematology/Oncology Fellowship, University of North Carolina at Chapel Hill School of Medicine, 1998 - 2001
  • Internal Medicine Residency, University of Michigan at Ann Arbor, 1995 - 1998
  • M.D., University of Virginia School of Medicine, 1995

Publications

Weiss, J, Kavanagh, B, Deal, A, Villaruz, L, Stevenson, J, Camidge, R, Borghaei, H, West, J, Kirpalani, P, Morris, D, Lee, C, Pecot, CV, Zagar, T, Stinchcombe, T, and Pennell, N. "Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib." Cancer Treatment and Research Communications 19 (February 26, 2019): 100126-null.

PMID
30852467
Full Text